Дмитрий Андреевич Ступин

Дмитрий Андреевич Ступин

Auto-generated profile, based on publicly available information

Дмитрий Андреевич Ступин

Irkutsk State Medical University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2018 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
ЛКЛюбовь Ильинична Колесникова
Любовь Ильинична Колесникова
ASAndrey A. Semendyaev
Andrey A. Semendyaev
ДСДмитрий Андреевич Ступин
Дмитрий Андреевич Ступин
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
ЛГЛюдмила Анатольевна Гребенкина
Людмила Анатольевна Гребенкина
АСАндрей Александрович Семендяев
Андрей Александрович Семендяев
Background: Information about involvement of general nonspecific reactions, in particular lipid peroxidation processes, in the progression of varicose veins of the pelvic (VVP) in women is still too scarce. Aims: To study the intensity of processes of lipid peroxidation and the activity of components of the antioxidant system in women with primary varicose veins of the pelvic at different stages of the disease. Materials and methods: 167 women of reproductive age were examined ― 137 with VVP and 30 made up a control group. All patients with VVP were divided into 3 groups depending on stages of the disease. Spectrophotometric and fluorometric methods of investigation were used. The study was conducted during 2012−2017. Results: It was revealed that the level of primary products of lipid peroxidation, diene conjugates, increased statistically significantly according to the stage of the disease by 1.25 times (in the 1st stage), 1.51 times (in the II stage) and 1.59 times (in the III stage) values. Changes in the content of final TBA-active products showed similar changes-an increase in the mean values for all stages of the disease relative to control (in 1.24, 1.17, and 1.77 times, respectively). Activity of glutathione peroxidase increased in stage 2 of VVP (1.19 times), with the maximum increase in stage III (1.42 times); activity of glutathione-S-transferase increased 1.18 times in the II stage of the disease. The concentration of GSH in the clinical groups was characterized by lower values with respect to the control (by 1.22 times in the 1st stage, in 1.64 times in the II stage), with the maximum decrease of this parameter in the III stage of VVP (3.67 times). The level of catalase activity increased in the I stage of VVP ― by 1.18 times and decreased in the III stage ― by 1.14 times with respect to the control. The activity of SOD showed similar changes with catalase ― in the form of increased activity at the 1st stage (1.35 times higher) and decreased values for II (1.35 times lower) and III (1.65 times lower) for the stages of VVP to the values of control. Conclusions: At progression of primary VVP in women (from the initial stage to the 3rd stage of the disease), there is an increase in imbalance in the lipid peroxidation − antioxidant defense system. Moreover, if the compensatory increase in activity of antioxidant enzymes is registered at stage 1 of the disease, then the most of the antioxidant defense factors decreases as relative to control values, and the initial stages of the disease.

27 October 2016 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
GGGus A.I. Gus
Gus A.I. Gus
SSSemendyaev A.A. Semendyaev
Semendyaev A.A. Semendyaev
SSStupin D.A. Stupin
Stupin D.A. Stupin
CCCherepanova M.A. Cherepanova
Cherepanova M.A. Cherepanova
BBBachurina S.M. Bachurina
Bachurina S.M. Bachurina
IEIrkutsk 664049 Irkutsk State Medical Academy Of Postgraduate Education
Irkutsk 664049 Irkutsk State Medical Academy Of Postgraduate Education

6 May 2019 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
GGGus A.I. Gus
Gus A.I. Gus
KKKolesnikova L.I. Kolesnikova
Kolesnikova L.I. Kolesnikova
SSSemendyaev A.A. Semendyaev
Semendyaev A.A. Semendyaev
SSStupin D.A. Stupin
Stupin D.A. Stupin
SSShcherbatykh A.V. Shcherbatykh
Shcherbatykh A.V. Shcherbatykh
IRIrkutsk Clinical Hospital At The Irkutsk-Passazhirskiy Railway Station Of Jsc Rzd
Irkutsk Clinical Hospital At The Irkutsk-Passazhirskiy Railway Station Of Jsc Rzd

1 March 2019 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKolesnikova L.I. Kolesnikova
Kolesnikova L.I. Kolesnikova
GGGus A.I. Gus
Gus A.I. Gus
TTTaranenko A.V. Taranenko
Taranenko A.V. Taranenko
SSSemendyaev A.A. Semendyaev
Semendyaev A.A. Semendyaev
SSStupin D.A. Stupin
Stupin D.A. Stupin
IRIrkutsk 3 Regional Oncology Center Of Minzdrav Of Russia
Irkutsk 3 Regional Oncology Center Of Minzdrav Of Russia

9 May 2024 in GYNECOLOGY
Verified
Journal Article
Open access
PDF file
DSDmitry A. Stupin
Dmitry A. Stupin
LKLyubov I. Kolesnikova
Lyubov I. Kolesnikova
ASAndrey A. Semendyaev
Andrey A. Semendyaev
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
DTDaria V. Tukhieva
Daria V. Tukhieva
ТВТухиева Дарья Владиславовна
Тухиева Дарья Владиславовна
Aim. To evaluate the clinical efficacy of complex antioxidant therapy (CAT) in the treatment of patients with pelvic varicose veins (PVV). Materials and methods. Patients with PVV (n=150) were divided into groups 1 and 2 of 75 subjects; the groups were comparable. Treatment in both groups included standard therapy with one of the venotropic agents (60 days). Patients of group 1 additionally received CAT for 30 days (1 course), in total 3 courses with 2-month intervals. Results. When assessing the parameters of the lipoperoxidation system (antioxidant protection) in group 1 during CAT combined with standard venotropic therapy, there was a statistically significant decrease in the levels of lipid hydroperoxides (p0.0001), diene conjugates (p=0.001), malonic dialdehyde (p0.0001), an increase in the levels of catalase (p0.0001), superoxide dismutase (p0.0001), glutathione peroxidase (p0.0001), glutathione reductase (p0.0001), glutathione-S-transferase (p=0.002) and the reduced glutathione content (p=0.032) compared to levels before treatment. The above group showed a decrease in the diameter of the pelvic varicose veins: internal iliac (p0.001), ovarian (p0.0001) and arcuate (p0.001), an increase in their blood flow velocity (p=0.003, 0.041, and 0.040, respectively), a decrease in the duration of retrograde flow to 0.3 cm. There was a decrease in pelvic pain (p0.0001), dysmenorrhea (p=0.024), dyspareunia (p=0.037), the frequency of irregular menstruation (p=0.031), an improvement in quality of life (p=0.047), pregnancy rate (p=0.013), the number of live births (p=0.004), and the duration of remission (p=0.047). Conclusion. The use of a combination of antioxidants superoxide dismutase 250 mg 2 times a day, acetyl-glutathione at 100 mg 2 times a day, and astaxanthin 400 mg/day for 30 days in 3 courses with 2-month intervals combined with venotropic therapy can significantly improve the treatment outcomes of patients with PVV.

26 June 2024 in ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»
Verified
Journal Article
Open access
PDF file
САСемендяев А.а.
Семендяев А.а.
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
СДСтупин Д.а.
Ступин Д.а.
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
NSNatalya Semenova
Natalya Semenova
КЛКолесникова Л.и.
Колесникова Л.и.
Несмотря на проводимые исследования в области патогенеза варикозной болезни вен малого таза (ВБВМТ), вопрос ангиогенеза (АГ) при ВВМТ освещен недостаточно. Системный подход к венозным дилатационным заболеваниям, в том числе с точки зрения АГ, расширит понимание патофизиологических механизмов ВРВМТ и побудит к поиску новых методов его коррекции. Цель исследования – оценка показателей ангиогенеза у женщин с различной степенью тяжести варикоза вен малого таза. Методика. Обследованы 183 пациентки с ВБВМТ, разделенные в соответствии с тяжестью заболевания на 3 группы: 1-я группа (легкая cтепень тяжести варикозного процесса, n=79); 2-я группа (среднетяжелая cтепень, n=63); 3-я группа (тяжелая степень, n=41). В качестве контроля использовались данные 30 практически здоровых женщин. Определение содержания в плазме периферической крови про- и антиангиогенных факторов проводили методом твердофазного иммуноферментного анализа. Результаты исследования показали наличие статистически значимых различий у пациенток с 1 стадией ВРВМТ в отношении более высоких значений содержания ангиогенина, PAI-1, сниженного уровня PDGF и TIMP-1 относительно контроля. Пациентки 2 стадии имели более высокие концентрации ангиогенина, ММР-8, ММР-9, PAI-1, сниженные уровни PDGF и TIMP-1 по сравнению с контрольными значениями. Третья стадия заболевания отличалась повышенными значениями содержания ангиогенина, ММР-8, ММР-9, FGF, PAI-1, сниженными уровнями PDGF и TIMP-1 по отношению с контрольным данным. Заключение. Данные результаты могут способствовать более точной оценке интенсивности и динамики прогрессирования варикозного изменения вен малого таза у женщин с целью оптимизации диагностики и разработки методов коррекции. Despite extensive studies, the role of angiogenesis (AG) in pelvic venous incompetence (PVI) is not sufficiently understood. A systematic approach to dilating venous diseases, including consideration AG, will expand understanding of the pathophysiological mechanisms of PVI and encourage the search for new methods for its correction. Thus, this study aimed to evaluate parameters of angiogenesis in women with varying degrees of PVI. Methods. We examined 183 patients with PVI, divided according to the severity of the disease into three groups: Stage 1 (mild PVI, n=79); Stage 2 (moderate PVI, n=63); Stage 3 (severe PVI, n=41). Control data were collected from 30 apparently healthy women. The contents of pro- and anti-angiogenic factors in peripheral blood plasma were determined by enzyme-linked, immunosorbent assay. The results showed higher angiogenin and PAI-1and lower PDGF and TIMP-1 in Stage 1 PVI compared to control values. Stage 2 patients had higher angiogenin, MMP-8, MMP-9, and PAI-1 and lower PDGF and TIMP-1 compared to control values. Stage 3 patients had higher angiogenin, MMP-8, MMP-9, FGF, PAI-1, and lower PDGF and TIMP-1 compared to control values. Conclusion. These findings provide a more accurate assessment of the intensity and dynamics of progressive PVI in women, which may lead to improved diagnosis and development of correctional therapy for PVI.